 |
市場調查報告書
商品編碼
1911263
2026-2030年全球月經藥物市場Global Menstrual Drugs Market 2026-2030 |
||||||
價格
簡介目錄
全球月經藥物市場預估在2025年至2030年間成長45.974億美元，預測期內複合年成長率（CAGR）為8.4%。本報告對全球月經藥物市場進行了全面分析，包括市場規模和預測、趨勢、成長要素和挑戰，以及對約25家公司的供應商分析。
該報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動市場成長的因素包括：全球對月經健康障礙的認知不斷提高、診斷技術的進步、重大的藥物創新和不斷擴大的治療方案、有利的報銷政策以及全球在女性健康方面不斷成長的醫療保健支出。
本研究採用客觀的方法，結合一手和二手訊息，包括來自主要行業相關人員的意見。報告包含全面的市場規模數據、區域細分分析、供應商格局以及對主要企業的分析。報告提供歷史數據和預測數據。
| 市場覆蓋範圍 | |
|---|---|
| 基準年 | 2026 |
| 目標期 | 2030 |
| 預測期 | 2026-2030 |
| 成長勢頭 | 加速度 |
| 2026 年與前一年相比 | 7.7% |
| 複合年成長率 | 8.4% |
| 增量 | 45.974億美元 |
該研究指出，非荷爾蒙療法的興起是未來幾年全球月經藥物市場成長的主要驅動力之一，而與數位健康的融合、對個人化醫療的追求以及對疾病修正治療而非症狀緩解的戰略關注，預計將在市場上產生巨大的需求。
目錄
第1章執行摘要
- 市場概覽
第2章 Technavio 分析
- 價格、生命週期、顧客購買籃、採用率和購買標準分析
- 投入與差異化因素的重要性
- 混淆來源
- 促進因素和挑戰的影響
第3章 市場情勢
- 市場生態系統
- 市場特徵
- 價值鏈分析
第4章 市場規模
- 市場定義
- 市場區隔分析
- 2025年市場規模
- 2025-2030年市場展望
第5章 市場規模表現
- 2020-2024年全球月經藥物市場
- 類型細分市場分析 2020-2024
- 2020-2024年按行政路線分類的細分市場分析
- 2020-2024年通路細分分析
- 2020-2024年區域市場分析
- 2020-2024年國家細分市場分析
第6章 定性分析
- 人工智慧的影響：全球月經藥物市場
第7章五力分析
- 五力摘要
- 買方的議價能力
- 供應商的議價能力
- 新進入者的威脅
- 替代品的威脅
- 競爭威脅
- 市場狀況
第8章 按類型分類的市場區隔
- 市場區隔
- 比較：按類型
- 荷爾蒙療法：市場規模及預測（2025-2030年）
- 止痛藥：市場規模及預測（2025-2030 年）
- 月經症候群 (PMS) 和月經焦慮症 (PMDD) 治療：市場規模和預測 2025-2030
- 月經調節藥物：市場規模及預測（2025-2030年）
- 子宮內膜異位症藥物：市場規模及預測（2025-2030年）
- 按類型分類的市場機會
9. 依給藥途徑進行市場區隔
- 市場區隔
- 比較：按給藥途徑
- 口服藥物：市場規模及預測（2025-2030年）
- 注射：市場規模及預測（2025-2030 年）
- 外用製劑：市場規模及預測（2025-2030年）
- 按給藥途徑分類的市場機會
第10章 按分銷管道進行市場細分
- 市場區隔
- 比較：按分銷管道
- 零售藥局：市場規模及預測（2025-2030 年）
- 醫院藥局：市場規模及預測（2025-2030年）
- 線上藥局：市場規模及預測（2025-2030 年）
- 按分銷管道分類的市場機會
第11章 客戶情況
- 客戶概覽
第12章 區域情勢
- 區域細分
- 區域比較
- 北美：市場規模及預測（2025-2030 年）
- 歐洲：市場規模及2025-2030年預測
- 亞洲：市場規模及2025-2030年預測
- 世界其他地區：市場規模及預測（2025-2030年）
- 各區域的市場機遇
第13章 促進因素、挑戰與機遇
- 市場促進因素
- 市場挑戰
- 促進因素和挑戰的影響
- 市場機遇
第14章 競爭格局
- 概述
- 競爭格局
- 令人困惑的局面
- 產業風險
第15章 競爭分析
- 公司簡介
- 企業排名指數
- 公司市場定位
- AbbVie Inc.
- Bayer AG
- Cipla Inc.
- Dr Reddys Laboratories Ltd.
- GlaxoSmithKline Plc
- Haleon Plc
- Johnson and Johnson Services
- Mallinckrodt Plc
- Perrigo Co. Plc
- Pfizer Inc.
- Reckitt Benckiser Group Plc
- Sanofi SA
- Sumitomo Chemical Co. Ltd.
- Teva Pharmaceutical Ltd.
- Zydus Lifesciences Ltd.
第16章附錄
簡介目錄
Product Code: IRTNTR80128
The global menstrual drugs market is forecasted to grow by USD 4597.4 mn during 2025-2030, accelerating at a CAGR of 8.4% during the forecast period. The report on the global menstrual drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing global awareness and improved diagnosis of menstrual health disorders, substantial pharmaceutical innovation and expansion of treatment portfolio, favorable reimbursement policies and increasing global healthcare expenditure on women health.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2026 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 7.7% |
| CAGR | 8.4% |
| Incremental Value | $4597.4 mn |
Technavio's global menstrual drugs market is segmented as below:
By Type
- Hormonal treatments
- Pain relief medications
- PMS and PMDD medications
- Menstrual regulation drugs
- Endometriosis treatments
By Route Of Administration
- Oral medications
- Injectables
- Topical applications
By Distribution Channel
- Retail pharmacies
- Hospital pharmacies
- Online pharmacies
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Russia
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the ascendancy of non-hormonal treatment modalities as one of the prime reasons driving the global menstrual drugs market growth during the next few years. Also, integration of digital health and pursuit of personalized medicine and strategic focus on disease-modifying therapies over symptomatic relief will lead to sizable demand in the market.
The report on the global menstrual drugs market covers the following areas:
- Global menstrual drugs market sizing
- Global menstrual drugs market forecast
- Global menstrual drugs market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global menstrual drugs market vendors that include AbbVie Inc., Adorefem, Bayer AG, Cipla Inc., Dr Reddys Laboratories Ltd., GlaxoSmithKline Plc, Haleon Plc, Johnson and Johnson Services, Leeford Healthcare Ltd., Mallinckrodt Plc, Maxwellia Ltd., Perrigo Co. Plc, Pfizer Inc., Reckitt Benckiser Group Plc, Sanofi SA, Sumitomo Chemical Co. Ltd., Teva Pharmaceutical Ltd., The Himalaya Drug Co., Walgreens Boots Alliance Inc., Zydus Lifesciences Ltd.. Also, the global menstrual drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Chart on Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Chart on Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
- 3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Chart on Market characteristics analysis
- 3.3 Value chain analysis
- Chart on Value chain analysis
4 Market Sizing
- 4.1 Market definition
- Data Table on Offerings of companies included in the market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
- 5.1 Global Menstrual Drugs Market 2020 - 2024
- Historic Market Size - Data Table on Global Menstrual Drugs Market 2020 - 2024 ($ million)
- 5.2 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- 5.3 Route of Administration segment analysis 2020 - 2024
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
- 5.4 Distribution Channel segment analysis 2020 - 2024
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 The AI impact on global menstrual drugs market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Type
- 8.1 Market segments
- Chart on Type - Market share 2025-2030 (%)
- Data Table on Type - Market share 2025-2030 (%)
- 8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 8.3 Hormonal treatments - Market size and forecast 2025-2030
- Chart on Hormonal treatments - Market size and forecast 2025-2030 ($ million)
- Data Table on Hormonal treatments - Market size and forecast 2025-2030 ($ million)
- Chart on Hormonal treatments - Year-over-year growth 2025-2030 (%)
- Data Table on Hormonal treatments - Year-over-year growth 2025-2030 (%)
- 8.4 Pain relief medications - Market size and forecast 2025-2030
- Chart on Pain relief medications - Market size and forecast 2025-2030 ($ million)
- Data Table on Pain relief medications - Market size and forecast 2025-2030 ($ million)
- Chart on Pain relief medications - Year-over-year growth 2025-2030 (%)
- Data Table on Pain relief medications - Year-over-year growth 2025-2030 (%)
- 8.5 PMS and PMDD medications - Market size and forecast 2025-2030
- Chart on PMS and PMDD medications - Market size and forecast 2025-2030 ($ million)
- Data Table on PMS and PMDD medications - Market size and forecast 2025-2030 ($ million)
- Chart on PMS and PMDD medications - Year-over-year growth 2025-2030 (%)
- Data Table on PMS and PMDD medications - Year-over-year growth 2025-2030 (%)
- 8.6 Menstrual regulation drugs - Market size and forecast 2025-2030
- Chart on Menstrual regulation drugs - Market size and forecast 2025-2030 ($ million)
- Data Table on Menstrual regulation drugs - Market size and forecast 2025-2030 ($ million)
- Chart on Menstrual regulation drugs - Year-over-year growth 2025-2030 (%)
- Data Table on Menstrual regulation drugs - Year-over-year growth 2025-2030 (%)
- 8.7 Endometriosis treatments - Market size and forecast 2025-2030
- Chart on Endometriosis treatments - Market size and forecast 2025-2030 ($ million)
- Data Table on Endometriosis treatments - Market size and forecast 2025-2030 ($ million)
- Chart on Endometriosis treatments - Year-over-year growth 2025-2030 (%)
- Data Table on Endometriosis treatments - Year-over-year growth 2025-2030 (%)
- 8.8 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Route of Administration
- 9.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
- 9.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- 9.3 Oral medications - Market size and forecast 2025-2030
- Chart on Oral medications - Market size and forecast 2025-2030 ($ million)
- Data Table on Oral medications - Market size and forecast 2025-2030 ($ million)
- Chart on Oral medications - Year-over-year growth 2025-2030 (%)
- Data Table on Oral medications - Year-over-year growth 2025-2030 (%)
- 9.4 Injectables - Market size and forecast 2025-2030
- Chart on Injectables - Market size and forecast 2025-2030 ($ million)
- Data Table on Injectables - Market size and forecast 2025-2030 ($ million)
- Chart on Injectables - Year-over-year growth 2025-2030 (%)
- Data Table on Injectables - Year-over-year growth 2025-2030 (%)
- 9.5 Topical applications - Market size and forecast 2025-2030
- Chart on Topical applications - Market size and forecast 2025-2030 ($ million)
- Data Table on Topical applications - Market size and forecast 2025-2030 ($ million)
- Chart on Topical applications - Year-over-year growth 2025-2030 (%)
- Data Table on Topical applications - Year-over-year growth 2025-2030 (%)
- 9.6 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
10 Market Segmentation by Distribution Channel
- 10.1 Market segments
- Chart on Distribution Channel - Market share 2025-2030 (%)
- Data Table on Distribution Channel - Market share 2025-2030 (%)
- 10.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- 10.3 Retail pharmacies - Market size and forecast 2025-2030
- Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
- Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
- Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
- 10.4 Hospital pharmacies - Market size and forecast 2025-2030
- Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
- Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
- 10.5 Online pharmacies - Market size and forecast 2025-2030
- Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million)
- Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million)
- Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
- 10.6 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- 12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- 12.3.1 US - Market size and forecast 2025-2030
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- 12.3.2 Canada - Market size and forecast 2025-2030
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- 12.3.3 Mexico - Market size and forecast 2025-2030
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- 12.4 Europe - Market size and forecast 2025-2030
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- 12.4.1 Germany - Market size and forecast 2025-2030
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- 12.4.2 UK - Market size and forecast 2025-2030
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- 12.4.3 France - Market size and forecast 2025-2030
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- 12.4.4 Italy - Market size and forecast 2025-2030
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- 12.4.5 Spain - Market size and forecast 2025-2030
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- 12.4.7 Russia - Market size and forecast 2025-2030
- Chart on Russia - Market size and forecast 2025-2030 ($ million)
- Data Table on Russia - Market size and forecast 2025-2030 ($ million)
- Chart on Russia - Year-over-year growth 2025-2030 (%)
- Data Table on Russia - Year-over-year growth 2025-2030 (%)
- 12.5 Asia - Market size and forecast 2025-2030
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- 12.5.1 China - Market size and forecast 2025-2030
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- 12.5.2 Japan - Market size and forecast 2025-2030
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- 12.5.3 India - Market size and forecast 2025-2030
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- 12.5.4 South Korea - Market size and forecast 2025-2030
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- 12.5.6 Thailand - Market size and forecast 2025-2030
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- 12.5.7 Singapore - Market size and forecast 2025-2030
- Chart on Singapore - Market size and forecast 2025-2030 ($ million)
- Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
- Chart on Singapore - Year-over-year growth 2025-2030 (%)
- Data Table on Singapore - Year-over-year growth 2025-2030 (%)
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- 12.6.1 Australia - Market size and forecast 2025-2030
- Chart on Australia - Market size and forecast 2025-2030 ($ million)
- Data Table on Australia - Market size and forecast 2025-2030 ($ million)
- Chart on Australia - Year-over-year growth 2025-2030 (%)
- Data Table on Australia - Year-over-year growth 2025-2030 (%)
- 12.6.2 UAE - Market size and forecast 2025-2030
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- 12.6.3 Brazil - Market size and forecast 2025-2030
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- 12.6.4 South Africa - Market size and forecast 2025-2030
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- 12.6.5 Saudi Arabia - Market size and forecast 2025-2030
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- 12.6.6 Turkey - Market size and forecast 2025-2030
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Increasing global awareness and improved diagnosis of menstrual health disorders
- Substantial pharmaceutical innovation and expansion of treatment portfolio
- Favorable reimbursement policies and increasing global healthcare expenditure on women health
- 13.2 Market challenges
- Persistent socio-cultural stigma and deficiencies in menstrual health education
- Adverse effect profiles of existing therapies and low patient adherence
- Stringent regulatory scrutiny and payer resistance to premium pricing
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Ascendancy of non-hormonal treatment modalities
- Integration of digital health and pursuit of personalized medicine
- Strategic focus on disease-modifying therapies over symptomatic relief
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
- 15.5 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
- 15.6 Cipla Inc.
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
- 15.7 Dr Reddys Laboratories Ltd.
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
- SWOT
- 15.8 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- 15.9 Haleon Plc
- Haleon Plc - Overview
- Haleon Plc - Business segments
- Haleon Plc - Key offerings
- Haleon Plc - Segment focus
- SWOT
- 15.10 Johnson and Johnson Services
- Johnson and Johnson Services - Overview
- Johnson and Johnson Services - Business segments
- Johnson and Johnson Services - Key news
- Johnson and Johnson Services - Key offerings
- Johnson and Johnson Services - Segment focus
- SWOT
- 15.11 Mallinckrodt Plc
- Mallinckrodt Plc - Overview
- Mallinckrodt Plc - Business segments
- Mallinckrodt Plc - Key news
- Mallinckrodt Plc - Key offerings
- Mallinckrodt Plc - Segment focus
- SWOT
- 15.12 Perrigo Co. Plc
- Perrigo Co. Plc - Overview
- Perrigo Co. Plc - Business segments
- Perrigo Co. Plc - Key offerings
- Perrigo Co. Plc - Segment focus
- SWOT
- 15.13 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
- 15.14 Reckitt Benckiser Group Plc
- Reckitt Benckiser Group Plc - Overview
- Reckitt Benckiser Group Plc - Business segments
- Reckitt Benckiser Group Plc - Key news
- Reckitt Benckiser Group Plc - Key offerings
- Reckitt Benckiser Group Plc - Segment focus
- SWOT
- 15.15 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
- 15.16 Sumitomo Chemical Co. Ltd.
- Sumitomo Chemical Co. Ltd. - Overview
- Sumitomo Chemical Co. Ltd. - Business segments
- Sumitomo Chemical Co. Ltd. - Key offerings
- Sumitomo Chemical Co. Ltd. - Segment focus
- SWOT
- 15.17 Teva Pharmaceutical Ltd.
- Teva Pharmaceutical Ltd. - Overview
- Teva Pharmaceutical Ltd. - Business segments
- Teva Pharmaceutical Ltd. - Key news
- Teva Pharmaceutical Ltd. - Key offerings
- Teva Pharmaceutical Ltd. - Segment focus
- SWOT
- 15.18 Zydus Lifesciences Ltd.
- Zydus Lifesciences Ltd. - Overview
- Zydus Lifesciences Ltd. - Business segments
- Zydus Lifesciences Ltd. - Key news
- Zydus Lifesciences Ltd. - Key offerings
- Zydus Lifesciences Ltd. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
